by on June 16, 2023
An extensive analysis on the market for ophthalmic drug delivery systems has been published by a reputable market research company, revealing significant development prospects in the years to come. The market is anticipated to grow at a stable compound annual growth rate (CAGR) of 6.9% from 2021 to 2031, reaching a valuation of $30,013.7 million. Ophthalmic illnesses are becoming more common, and this is one of the main factors driving market expansion. The prevalence of eye-related condition...
26 views 0 likes